EFFECT OF TICAGRELOR AND CLOPIDOGREL ON CORONARY MICROCIRCULATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Marco Scanavini Filho,Otavio Berwanger,Wilson Mathias Júnior,Miguel Osman Aguiar,Hsu Po-Chiang,Luciano Moreira Baracioli,Felipe Gallego Lima,Fernando Menezes,Talia Dalcoquio,Remo Holanda de Mendonça Furtado,Fabio De Luca,Delcio Uezato,José Antonio Franchini Ramires,Roberto Kalil-Filho,José Carlos Nicolau

EFFECT OF TICAGRELOR AND CLOPIDOGREL ON CORONARY MICROCIRCULATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

2019

Marco Scanavini Filho
Otavio Berwanger
Wilson Mathias Júnior
Miguel Osman Aguiar
Hsu Po-Chiang
Luciano Moreira Baracioli
Felipe Gallego Lima
Fernando Menezes
Talia Dalcoquio
Remo Holanda de Mendonça Furtado
Fabio De Luca
Delcio Uezato
José Antonio Franchini Ramires
Roberto Kalil-Filho
José Carlos Nicolau

About 40% of patients (pts) with ST-segment elevation myocardial infarction successfully reperfused have some degree of microcirculation flow (MF) compromised; this leads to worse left ventricular remodeling and higher mortality. Clopidogrel is the only antiplatelet drug with proved benefit on MF.

Keywords:

Clopidogrel
Microcirculation
Myocardial infarction
Cardiology
Diabetes mellitus
Ticagrelor
Internal medicine
Medicine
Ventricular remodeling
Antiplatelet drug
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations